Examkin

Soru

Zorluk: ZorGynecologic Oncology

An evaluation is requested for a female patient experiencing persistent, unpredictable vaginal spotting over the last 8 weeks. The patient is 38 years of age and has never been pregnant. Her gynecologic history is notable for oligomenorrhea since adolescence, with menses occurring only two to three times per year. She also reports long-standing struggles with excess facial hair and obesity; her current body mass index is 37 kg/m². Pelvic examination reveals no active bleeding from the cervical os and normal-appearing vaginal mucosa. Transvaginal ultrasonography is performed and demonstrates an endometrial stripe measuring 17 mm in thickness, alongside bilaterally enlarged ovaries containing numerous small peripheral follicles. Which of the following is the most appropriate next step in the management of this patient's condition?

  1. Office endometrial biopsyCevap
  2. B
    Outpatient hysteroscopy with dilation and curettage
  3. C
    Insertion of a levonorgestrel-releasing intrauterine device
  4. D
    Measurement of serum 17-hydroxyprogesterone level
  5. E
    Initiation of cyclic oral progestin therapy

Cevap

Office endometrial biopsy
The most appropriate next step is an office endometrial biopsy. This patient presents with abnormal uterine bleeding in the setting of chronic anovulation (suggested by oligomenorrhea, hyperandrogenism, and polycystic-appearing ovaries) and obesity. In anovulatory cycles, the endometrium is exposed to continuous estrogen without the stabilizing effect of progesterone, leading to endometrial proliferation. Peripheral aromatization of androgens to estrone in adipose tissue further compounds this risk. Although endometrial biopsy is universally recommended for abnormal bleeding in women aged 45 years and older, it is also explicitly indicated in women under 45 years who have significant risk factors for unopposed estrogen exposure. Her significantly thickened endometrial stripe (17 mm) reinforces the urgent need to rule out malignant or premalignant changes before initiating any medical therapy.

Adım Adım Çözüm

1
Identify the patient's risk factors for endometrial pathology based on the clinical presentation.
The patient has chronic anovulation (evidenced by oligomenorrhea and polycystic-appearing ovaries) and severe obesity (BMI 37 kg/m²).
These factors result in prolonged, unopposed estrogen exposure, significantly increasing the risk of endometrial hyperplasia and carcinoma.
2
Evaluate the indication for endometrial sampling based on patient age and risk profile.
Although the patient is under 45 years old, her significant risk factors and thickened endometrium (17 mm) meet the criteria for immediate endometrial sampling.
Guidelines mandate biopsy in women under 45 with abnormal uterine bleeding if they have a history of unopposed estrogen exposure.
3
Select the most appropriate initial diagnostic modality.
An office endometrial biopsy is chosen over immediate treatment or more invasive procedures.
A definitive tissue diagnosis must precede any hormonal treatment to accurately rule out endometrial cancer.

Anahtar Kavram

In women under 45 years of age presenting with abnormal uterine bleeding, an office endometrial biopsy is required if there are significant risk factors for unopposed estrogen exposure (such as obesity and chronic anovulation) to rule out endometrial hyperplasia and carcinoma.
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

Gynecologic Oncology

Bu konudan daha fazla soru